癌症治疗对男性生育能力的影响:过去和现在
Kathleen Duffin1, Rod T Mitchell2, Mark F H Brougham3
1Department of Biomedical Sciences, University of Edinburgh, George Square, Edinburgh, EH8 9XD, UK; Royal Hospital for Children and Young People, 50 Little France Crescent, Edinburgh, EH16 4TJ, UK.
Molecular aspects of medicine
|September 12, 2024
概括
癌症疗法已经进步,改善了生存率,但危及生育能力. 对于儿童和成人癌症患者来说,由于持续的淋巴细胞毒性风险,生育能力的保护仍然至关重要.
科学领域:
- 在瘤学瘤学.
- 生殖医学 生殖医学
- 癌症治疗方法 癌症治疗方法
背景情况:
- 癌症治疗的进步提高了生存率,特别是在儿科瘤学中.
- 许多癌症治疗都带有淋巴细胞毒性风险,影响未来的生育能力.
- 保护生育能力对于儿童和成人癌症患者至关重要.
研究的目的:
- 为了回顾过去20年来癌症治疗的演变.
- 评估这些不断发展的疗法对治疗后生育能力的影响.
- 为了强调生育保护计划的持续重要性.
主要方法:
- 关于癌症治疗演变的文献综述.
- 对治疗方式及其已知的淋巴毒性作用的分析.
- 评估当前的生育保护指南和挑战.
主要成果:
- 癌症治疗已经转向向治疗,减少一般毒性.
- 尽管总体毒性降低,但淋巴细胞毒性仍然是一个重大问题.
- 由于不断发展的多模式方法,评估治疗后不孕症风险是复杂的.
结论:
- 保护生育能力是全面癌症护理的重要组成部分.
- 转向向疗法的转变并没有消除不孕症的风险.
- 需要持续保持警和更新生育保护策略.
相关概念视频
Infertility in Males
255
Male infertility affects millions of couples worldwide, arising from various factors that impact different stages of the reproductive process. An endocrine imbalance resulting from conditions like hypogonadism, Klinefelter syndrome, or pituitary disorders can disrupt hormone levels and reduce sperm production. Testicular defects, such as tumors, cryptorchidism, atrophic testes, abnormal sperm morphology, and low sperm count or motility, may arise due to genetic factors, structural...
255
Disorders of the Male Reproductive System
358
Men's health issues are increasingly recognized as significant, with several conditions posing common threats. Among these, testicular cancer is especially prevalent in younger men, particularly those aged 20 to 35 years. The disease often manifests as a painless mass in the testicles, sometimes accompanied by a sensation of heaviness or a dull ache.
Prostate disorders are another major concern. These conditions can impair urinary flow due to the prostate's location around the urethra....
Prostate disorders are another major concern. These conditions can impair urinary flow due to the prostate's location around the urethra....
358
Spermatogenesis
102.3K
Spermatogenesis is the process by which haploid sperm cells are produced in the male testes. It starts with stem cells located close to the outer rim of seminiferous tubules. These spermatogonial stem cells divide asymmetrically to give rise to additional stem cells (meaning that these structures “self-renew”), as well as sperm progenitors, called spermatocytes. Importantly, this method of asymmetric mitotic division maintains a population of spermatogonial stem cells in the male...
102.3K
Cancer Therapies
7.6K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.6K
Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K
Cancer Survival Analysis
334
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
334


